Characterization of a multidrug-resistant chronic myeloid leukemia cell line presenting multiple resistance mechanisms

Collateral sensitivity as a strategy against cancer multidrug resistance

(2012) Kristen M. Pluchino et al.   DRUG RESISTANCE UPDATES

Advances in the treatment of chronic myeloid leukemia

(2011) Anna M Eiring et al.   BMC Medicine

Identification of Xanthones as Selective Killers of Cancer Cells Overexpressing the ABC Transporter MRP1

(2011) Estelle Genoux-Bastide et al.   ChemMedChem

Recent developments in drug resistance mechanism in chronic myeloid leukemia: a review

(2011) Shantashri Vaidya et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Iodination of verapamil for a stronger induction of death, through GSH efflux, of cancer cells overexpressing MRP1

(2010) Régis Barattin et al.   BIOORGANIC & MEDICINAL CHEMISTRY

Drug Transporters and Imatinib Treatment: Implications for Clinical Practice

(2010) K. Eechoute et al.   CLINICAL CANCER RESEARCH

Variation of MDR proteins expression and activity levels according to clinical status and evolution of CML patients

(2010) Flavia C. Vasconcelos et al.   CYTOMETRY PART B-CLINICAL CYTOMETRY

Is resistance useless? Multidrug resistance and collateral sensitivity

(2009) Matthew D. Hall et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Imatinib resistance in multidrug-resistant K562 human leukemic cells

(2008) Yanina Assef et al.   LEUKEMIA RESEARCH

The chemokine interleukin-8 and the surface activation protein CD69 are markers for Bcr-Abl activity in chronic myeloid leukemia

(2008) Oliver Hantschel et al.   Molecular Oncology

The Role of Cellular Accumulation in Determining Sensitivity to Platinum-Based Chemotherapy

(2007) Matthew D. Hall et al.   Annual Review of Pharmacology and Toxicology